NCT04494074

Brief Summary

The best strategy for managing fever in patients with septic shock remains unknown. In a pilot study, the investigators showed that fever control at normothermia allowed a better control of shock and evolution of organ failures. In this second trial the investigators will conduct a multicentre, open-label, randomized controlled, superiority trial in which two strategies will be compared:

  1. 1.Respect of fever
  2. 2.Fever control at normothermia using external cooling The primary end point will be d-60 mortality.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
820

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

33 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Oct 2022Dec 2026

First Submitted

Initial submission to the registry

July 28, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2020

Completed
2.2 years until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

4.2 years

First QC Date

July 28, 2020

Last Update Submit

December 9, 2024

Conditions

Keywords

External cooling,FeverARDS

Outcome Measures

Primary Outcomes (1)

  • Mortality

    All causes mortality

    Day 60 from randomization

Secondary Outcomes (12)

  • Evolution of SOFA Score

    Up to Day 7

  • Number of ventilator free days

    Day 28

  • Number of renal replacement therapy free days

    Day 28

  • Number of vasopressor free days

    Day 28

  • Mortality

    Day 28

  • +7 more secondary outcomes

Study Arms (2)

Fever Control by external cooling

EXPERIMENTAL

External cooling during 48 hours to obtain normothermia

Other: External Cooling

Fever respected, no cooling

NO INTERVENTION

Fever respect without any antipyretic therapy

Interventions

External Cooling

Fever Control by external cooling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Documented or suspected infection either communautary or hospital acquired
  • Septic shock defined by the need for vasopressor and lactate\>2 mmol/l despite adequate fluid resuscitation (sepsis-3 definition)
  • Patients under invasive mechanical ventilation
  • Body core temperature\>38.3°C
  • Intravenous sedation or opioids
  • Ongoing antimicrobial treatment and/or intervention for infection source control
  • Attending physician confirms clinical equipoise without substantial risk if the patient participates in the trial

You may not qualify if:

  • Cardiac arrest within previous 7 days
  • Acute brain injury within previous 7 days
  • Extensive burns or epidermal necrolysis
  • \<18 years old
  • Body core temperature \>41°C
  • Under legal guardianship
  • No affiliation with the French health-care system
  • Pregnancy
  • Participation in another interventional study with mortality as the primary endpoint
  • An investigator's decision not to resuscitate
  • Patient already recruited in the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (33)

CHU Amiens

Amiens, France

RECRUITING

CHU Angers

Angers, France

RECRUITING

CH Victor Dupouy

Argenteuil, France

RECRUITING

Hôpital Nord Franche Comté

Belfort, France

RECRUITING

CH Cholet

Cholet, France

RECRUITING

Centre hospitalier intercommunal de Créteil

Créteil, France

RECRUITING

Hôpital Henri Mondor

Créteil, France

ACTIVE NOT RECRUITING

CHD Dijon

Dijon, France

RECRUITING

CHU Grenoble

Grenoble, France

RECRUITING

GH Est Francilien

Jossigny, France

RECRUITING

CHD Vendée

La Roche-sur-Yon, France

RECRUITING

CHU Kremlin Bicetre

Le Kremlin-Bicêtre, France

ACTIVE NOT RECRUITING

CHU Le Mans

Le Mans, France

RECRUITING

CH Lens

Lens, 62300, France

NOT YET RECRUITING

CH Libourne

Libourne, France

RECRUITING

Hôpital Saint Joseph Saint Luc

Lyon, 69001, France

NOT YET RECRUITING

Hôpital de la Croix-Rousse

Lyon, France

RECRUITING

Hôpital Timone

Marseille, France

ACTIVE NOT RECRUITING

CHR Metz Hôpital de Mercy

Metz, France

NOT YET RECRUITING

GRH Mulhouse

Mulhouse, France

RECRUITING

CHU Hotel Dieu

Nantes, France

RECRUITING

CHU Archet 1

Nice, France

ACTIVE NOT RECRUITING

Hôpital Pasteur

Nice, France

RECRUITING

Hopital Lariboisière - Réanimation Médicale

Paris, France

RECRUITING

Hôpital Lariboisière -Réanimation chirurgicale

Paris, France

RECRUITING

CHU La Milétrie Poitiers

Poitiers, France

RECRUITING

CHU Reims

Reims, France

ACTIVE NOT RECRUITING

CHU Charles Nicolle

Rouen, France

RECRUITING

CHU Réunion Sud

Saint-Denis, France

RECRUITING

Hôpital FOCH

Suresnes, France

RECRUITING

CH BIGORRE SITE GESPE Tarbes

Tarbes, France

RECRUITING

CHBA Vannes-Auray

Vannes, France

RECRUITING

Centre Hospitalier Mignot

Versailles, France

RECRUITING

Related Publications (1)

  • Guenegou-Arnoux A, Murris J, Bechet S, Jung C, Auchabie J, Dupeyrat J, Anguel N, Asfar P, Badie J, Carpentier D, Chousterman B, Bourenne J, Delbove A, Devaquet J, Deye N, Dumas G, Dureau AF, Lascarrou JB, Legriel S, Guitton C, Janniere-Nartey C, Quenot JP, Lacherade JC, Maizel J, Mekontso Dessap A, Mourvillier B, Petua P, Plantefeve G, Richard JC, Robert A, Saccheri C, Vong LVP, Katsahian S, Schortgen F; REVA Network. Protocol for fever control using external cooling in mechanically ventilated patients with septic shock: SEPSISCOOL II randomised controlled trial. BMJ Open. 2024 Jan 29;14(1):e069430. doi: 10.1136/bmjopen-2022-069430.

MeSH Terms

Conditions

Shock, SepticFever

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockBody Temperature ChangesSigns and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2020

First Posted

July 31, 2020

Study Start

October 1, 2022

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 10, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Strictly anonymized data will be available upon justified request from the coordinating investigator and the study sponsor

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
After publication upon justified request from the coordinating investigator and the study sponsor

Locations